Repeated Endobiliary Radiofrequency Ablation Plus Durvalumab, Gemcitabine, and Cisplatin for Unresectable Extrahepatic Cholangiocarcinoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jae Hee Cho, Professor
Department of Internal Medicine, Institute of Gastroenterology, Gangnam Severance Hospital, Yonsei University College of Medicine
Principal Investigator - Tadahisa Inoue, Associate Professor
Department of Gastroenterology, Aichi Medical University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Aichi Medical University
Aichi, Japan
Recruiting - Nagoya City University Hospital
Aichi, Japan
Recruiting - Nagoya City University Midori Municipal Hospital
Aichi, Japan
Recruiting - Gifu University Hospital
Gifu, Japan
Recruiting
- Pusan National University Hospital
Busan, South Korea
Recruiting - Gangnam Severance Hospital, Yonsei University College of Medicine
Seoul, South Korea
Recruiting - Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine
Seoul, South Korea
Recruiting - Severance Hospital, Yonsei University College of Medicine
Seoul, South Korea
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Nov 2025
- Primary completion
- 31 Dec 2027
- Completion
- 31 Dec 2030
- Last update posted
- 13 Jan 2026
- Registered enrollment
- 120
- Registry id
- NCT07235007
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.